Literature DB >> 30199009

High Throughput, Absolute Determination of the Content of a Selected Protein at Tissue Levels Using Quantitative Dot Blot Analysis (QDB).

Xiaoying Qi1, Yunyun Zhang2, Yuan Zhang1, Tianhui Ni3, Wenfeng Zhang2, Chunhua Yang1, Jia Mi4, Jiandi Zhang5, Geng Tian6.   

Abstract

Lacking a convenient, quantitative, high throughput immunoblot method for absolute determination of the content of a specific protein at cellular and tissue level significantly hampers the progress in proteomic research. Results derived from currently available immunoblot techniques are also relative, preventing any efforts to combine independent studies with a large-scale analysis of protein samples. In this study, we demonstrate the process of quantitative dot blot analysis (QDB) to achieve absolute quantification in a high throughput format. Using a commercially available protein standard, we are able to determine the absolute content of capping actin protein, gelsolin-like (CAPG) in protein samples prepared from three different mouse tissues (kidney, spleen, and prostate) together with a detailed explanation of the experimental details. We propose the QDB analysis as a convenient, quantitative, high throughput immunoblot method of absolute quantification of individual proteins at the cellular and tissue level. This method will substantially aid biomarker validation and pathway verification in various areas of biological and biomedical research.

Entities:  

Mesh:

Year:  2018        PMID: 30199009      PMCID: PMC6231693          DOI: 10.3791/56885

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

1.  Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes.

Authors:  E Engvall; K Jonsson; P Perlmann
Journal:  Biochim Biophys Acta       Date:  1971-12-28

Review 2.  Antibody-based proteomics and biomarker research - current status and limitations.

Authors:  Corinne Solier; Hanno Langen
Journal:  Proteomics       Date:  2014-03       Impact factor: 3.984

3.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Authors:  Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

4.  A proposal for validation of antibodies.

Authors:  Mathias Uhlen; Anita Bandrowski; Steven Carr; Aled Edwards; Jan Ellenberg; Emma Lundberg; David L Rimm; Henry Rodriguez; Tara Hiltke; Michael Snyder; Tadashi Yamamoto
Journal:  Nat Methods       Date:  2016-09-05       Impact factor: 28.547

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

7.  A dot-immunobinding assay for monoclonal and other antibodies.

Authors:  R Hawkes; E Niday; J Gordon
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

8.  Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure.

Authors:  J Renart; J Reiser; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

9.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.

Authors:  C P Paweletz; L Charboneau; V E Bichsel; N L Simone; T Chen; J W Gillespie; M R Emmert-Buck; M J Roth; E F Petricoin III; L A Liotta
Journal:  Oncogene       Date:  2001-04-12       Impact factor: 9.867

10.  Quantitative dot blot analysis (QDB), a versatile high throughput immunoblot method.

Authors:  Geng Tian; Fangrong Tang; Chunhua Yang; Wenfeng Zhang; Jonas Bergquist; Bin Wang; Jia Mi; Jiandi Zhang
Journal:  Oncotarget       Date:  2017-04-19
View more
  4 in total

1.  Dot-Blotting: A Quick Method for Expression Analysis of Recombinant Proteins.

Authors:  Vibhor Mishra
Journal:  Curr Protoc       Date:  2022-09

2.  Improving Prognosis of Surrogate Assay for Breast Cancer Patients by Absolute Quantitation of Ki67 Protein Levels Using Quantitative Dot Blot (QDB) Method.

Authors:  Junmei Hao; Yan Lyu; Jiarui Zou; Yunyun Zhang; Shuishan Xie; Lili Jing; Fangrong Tang; Jiahong Lyu; Wenfeng Zhang; Jianbo Zhang; Xunting Wang; Kuisheng Chen; Jiandi Zhang
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

3.  Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients.

Authors:  Junmei Hao; Wenfeng Zhang; Yan Lyu; Jiarui Zou; Yunyun Zhang; Jiahong Lyu; Jianbo Zhang; Shuishan Xie; Cuiping Zhang; Jiandi Zhang; Fangrong Tang
Journal:  Front Oncol       Date:  2021-11-09       Impact factor: 6.244

4.  A Ponceau S Staining-Based Dot Blot Assay for Rapid Protein Quantification of Biological Samples.

Authors:  Dario Lucas Helbing; Leopold Böhm; Nova Oraha; Leonie Karoline Stabenow; Yan Cui
Journal:  Gels       Date:  2022-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.